Top Section/Ad
Top Section/Ad
Most recent
Geopolitics takes a back seat as earnings season weighs on euro corporate supply
Attractive spreads available as Air Liquide lines up Swiss franc debut
Life science, utilities and industrials dominate supply after big tech's big splurge
Fresh issuance expected to keep new issue premiums elevated
More articles/Ad
More articles/Ad
More articles
-
GlaxoSmithKline, the UK pharmaceutical company, launched a three tranche bond issue on Monday. Its sterling curve was trading so flat that it started with the same spread on the long eight and 15 year tranches. -
Jacques Callaghan, formerly of Macquarie Capital, has joined HSBC as head of UK mid-market M&A, concentrating on a wedge of companies that are important to the bank’s new strategy.
-
The Asian dollar bond market is set for a quiet week for issuance because of public holidays across a number of countries and as investors continue to battle volatility induced by Covid-19 and renewed US-China trade tensions.
-
The coronavirus has made fantastical numbers commonplace in the corporate bond market. Everywhere one looks, results are being published that in any other time would herald the sudden collapse of companies. But you wouldn’t guess that from looking at the corporate bond market.
-
Corporate bond market participants are trying to decipher what the market will look like once lockdowns start lifting across Europe. A hierarchy of industries is forming in terms of access to capital markets, with those from a handful of major global sectors expected to remain shut out for a long while yet. Mike Turner reports.
-
Corporate bond bankers expect May to be a blockbuster month, as syndicate officials say that coronavirus pandemic fatigue has set in and the market has stopped worrying about it.
